Private Advisor Group’s Immix Biopharma IMMX Stock Holding History

Private Advisor Group’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$364K	Buy	35,325 +600	+2%	+$5.57K	﹤0.01%	1998
2026 Q1	$316K	Buy	34,725 +3,000	+9%	+$22K	﹤0.01%	2153
2025 Q4	$166K	Buy	31,725 +500	+2%	+$2.06K	﹤0.01%	2427
2025 Q3	$65.3K	Hold	31,225	–	–	﹤0.01%	2443
2025 Q2	$64.6K	Hold	31,225	–	–	﹤0.01%	2345
2025 Q1	$52.5K	Hold	31,225	–	–	﹤0.01%	2234
2024 Q4	$68.7K	Sell	31,225 -3,100	-9%	-$5.66K	﹤0.01%	2201
2024 Q3	$51.1K	Sell	34,325 -30,850	-47%	-$62.1K	﹤0.01%	2346
2024 Q2	$129K	Sell	65,175 -33,600	-34%	-$77.2K	﹤0.01%	2204
2024 Q1	$303K	Sell	98,775 -1,000	-1%	-$3.87K	﹤0.01%	1825
2023 Q4	$690K	Buy	+99,775	New	+$452K	0.01%	1303

Other funds holding IMMX

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Private Advisor Group's IMMX Position: Q2 2026 in Review

Private Advisor Group increased its Immix Biopharma (IMMX) stake by 1.7% in Q2 2026, buying an estimated $5.57K and bringing the position to 35,325 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #1998.

Private Advisor Group first reported a position in IMMX in Q4 2023 and has held it in 11 quarters since. The position peaked at $690K in Q4 2023. 12 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

Private Advisor Group held 35,325 shares of Immix Biopharma worth $364K as of Q2 2026.
Private Advisor Group bought 600 Immix Biopharma shares in Q2 2026, an estimated $5.57K.
Immix Biopharma made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1998 holding.
Private Advisor Group first reported a position in Immix Biopharma in Q4 2023 and has held it in 11 quarters since.
Private Advisor Group's Immix Biopharma position peaked at $690K in Q4 2023.
12 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.